More
    Guided Solutions - Connecting Talent With Innovation/div>

    GS MedTech Funding Tracker – Blackstone, Diagens, and more

    From a record-setting life sciences fund to growth rounds in AI and neurotech, this week’s MedTech deals are fueling clinical validation and global expansion. Details follow below. Blackstone announces final close of $6.3B Life Sciences...

    GS MedTech Funding Tracker – Blackstone, Diagens, and more

    From a record-setting life sciences fund to growth rounds in AI and neurotech, this week’s MedTech deals are fueling clinical validation and global expansion....

    Mediwhale secures $13.1M in Series C funding, preparing for IPO

    Medical AI company Mediwhale said it completed a 20 billion won ($13.1 million) Series C funding round. Premier Partners led the investment, with KB Investment,...

    StairMed raises $73М to advance BMI and DBS system development

    China’s StairMed Technology has raised RMB 500 million ($72.7m) to advance its brain-machine interface (BMI) and deep-brain stimulation (DBS) technologies to advance treatment options...

    Vdyne wins FDA IDE to study tricuspid valve replacement

    Vdyne announced that it received FDA investigational device exemption (IDE) for a pivotal trial evaluating its heart valve system. Maple Grove, Minnesota-based Vdyne develops a...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Data supports Boston Scientific Watchman FLX in stroke reduction

    Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system. Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...

    iPerf enrolls first patient in study of dual-flow femoral artery cannula

    iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...

    Providence Medical enrols first patients in CORUS-LX system trial

    Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease. The...

    Senseonics reports sustained year-long CGM implant outcomes

    Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM. Real-world evidence demonstrated the long-term performance and positive...

    Innovation

    Regulatory Approvals

    GS MedTech Funding Tracker – Blackstone, Diagens, and more

    From a record-setting life sciences fund to growth rounds in AI and neurotech, this week’s MedTech deals are fueling clinical validation and global expansion....

    Mediwhale secures $13.1M in Series C funding, preparing for IPO

    Medical AI company Mediwhale said it completed a 20 billion won ($13.1 million) Series C funding round. Premier Partners led the investment, with KB Investment,...

    StairMed raises $73М to advance BMI and DBS system development

    China’s StairMed Technology has raised RMB 500 million ($72.7m) to advance its brain-machine interface (BMI) and deep-brain stimulation (DBS) technologies to advance treatment options...

    Vdyne wins FDA IDE to study tricuspid valve replacement

    Vdyne announced that it received FDA investigational device exemption (IDE) for a pivotal trial evaluating its heart valve system. Maple Grove, Minnesota-based Vdyne develops a...

    M&A

    Archives

    Latest articles